The Z-drugs zolpidem, zopiclone, and zaleplon were hailed as the innovative hypnotics of
the new millennium, an improvement to traditional benzodiazepines in the management of …

Zolpidem is an imidazopyridine agent that is indicated for the short term (≤ 4 weeks)
treatment of insomnia (recommended dosage 10 mg/day in adults and 5 or 10 mg/day in the …

Abstract Insomnia affects 30–35% of people living in developed countries. The impact of
insomnia on daytime functioning and its relationship with medical and psychiatric illnesses …

Zolpidem is one of the newer medications developed for the treatment of insomnia. It is an
imidazopyridine agent that is an alternative to the typical sedative-hypnotic agents. Zolpidem …

A review with 103 references. Fluoxetine is the parent drug of the SSRI (selective serotonin
reuptake inhibitor) antidepressant class, and is still one of the most highly used drugs of this …

Introduction Insomnia is a stress-related sleep disorder, may favor a state of allostatic
overload impairing brain neuroplasticity, stress immune and endocrine pathways, and may …

Concise and authoritative, Clinical Toxicology: Principles and Mechanisms examines the
complex interactions associated with clinical toxicological events and chemical exposure or …

Background Insomnia is a major public health issue affecting between 6% to 10% of the
adult population in Western countries. Eszopiclone is a hypnotic drug belonging to a newer …

The first choice group of psychotropic agents in schizophrenia is neuroleptics. However, this
treatment is not effective in all patients and with every symptom. We summarize papers …

Objective: Zolpidem, a nonbenzodiazepine hypnotic, is very effective and widely prescribed
in clinical practice for the treatment of insomnia and is thought to have few adverse effects …